This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)
C3_URINARY_TRACT_NAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
251 |
4. Check minimum number of eventsNone |
251 |
5. Include endpointsNone |
251 |
6. Filter based on genotype QC (FinnGen only) |
251 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 251 | 59 | 192 |
| Unadjusted period prevalence (%) | 0.07 | 0.02 | 0.08 |
| Median age at first event (years) | 70.59 | 68.37 | 71.28 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 93
- Matched controls
- 931
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UKC02
NOMESCO Finland
Cystoscopy
47.0
52.1
79
99
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
50.7
44
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
315.4
40.3
38
*
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
33.3
30
*
130
Kela drug reimbursment
Malignant tumour
+∞
31.0
28
*
R31
ICD-10 Finland
Unspecified haematuria
16.0
27.1
49
60
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
26.3
24
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
336.9
26.1
25
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
25.1
23
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
21.7
20
*
UKB02
NOMESCO Finland
Retrograde ureteroscopy
75.2
21.0
23
*
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
+∞
20.6
19
*
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
251.3
20.4
20
*
H02AB02
ATC
dexamethasone; systemic
71.0
19.9
22
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
19.4
18
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
19.4
18
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
+∞
19.4
18
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
18.3
17
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
35.4
17.5
22
8
WX302
NOMESCO Finland
Thoracal epidural anesthesy
50.2
17.1
20
5
8120/3-C68.0
ICD-O-3
Transitional cell carcinoma, NOS, of urethra
+∞
16.1
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
7.5
15.6
43
95
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
95.1
15.1
16
*
ZX136
NOMESCO Finland
Intravesicalis
+∞
15.0
14
*
8120/3-C68.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of urinary organs
+∞
15.0
14
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
27.8
15.0
20
9
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
13.9
13
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.9
13
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
162.8
13.8
14
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
6.9
13.2
37
81
JN4AD
NOMESCO Finland
Body CT examination
19.5
12.8
19
12
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
12.8
12
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.2
12.6
30
51
B01AB10
ATC
tinzaparin; parenteral
16.7
12.1
19
14
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
+∞
11.7
11
*
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
+∞
11.7
11
*
JN4CD
NOMESCO Finland
Very extensive body CT
23.8
11.6
16
8
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
29.4
11.6
15
6
JN4BD
NOMESCO Finland
Extensive body CT
14.6
11.5
19
16
Z51.5
ICD-10 Finland
Palliative care
15.6
11.2
18
14
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
25.1
11.1
15
7
J01EA01
ATC
trimethoprim; systemic
5.1
10.8
40
119
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
123.3
10.7
11
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
10.6
10
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
10.6
10
*
8000/3-C68.9
ICD-O-3
Neoplasm, malignant of urinary system, NOS
+∞
10.6
10
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
10.6
10
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.6
10.3
25
43
XKD00
NOMESCO Finland
Uroflowmetry
4.8
9.9
39
122
XX3DW
NOMESCO Finland
Time consuming IT work
12.7
9.8
17
16
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
9.5
9
*
TJF80
NOMESCO Finland
Ostomy education
+∞
9.5
9
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.5
9
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
9.5
9
*
D41.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urethra
+∞
9.5
9
*
J01MA12
ATC
levofloxacin; systemic
4.8
9.4
36
108
A04AA01
ATC
ondansetron; systemic, rectal
41.1
9.2
11
*
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
+∞
8.5
8
*
J01MA02
ATC
ciprofloxacin; systemic
3.5
7.8
57
290
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.2
7.5
32
104
WF002
NOMESCO Finland
Radical radiotherapy
86.7
7.5
8
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
17.6
7.4
11
7
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
+∞
7.4
7
*
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
+∞
7.4
7
*
8070/3-C68.0
ICD-O-3
Squamous cell carcinoma, NOS, of urethra
+∞
7.4
7
*
116
Kela drug reimbursment
Prostate cancer
+∞
7.4
7
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
7.4
7
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
+∞
7.4
7
*
TKC20
NOMESCO Finland
Catheterisation of bladder
6.2
7.1
19
37
R33
ICD-10 Finland
Retention of urine
4.8
7.0
24
63
U99
ICPC
Urinary disease other
43.3
6.9
8
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.9
6.7
16
27
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
74.8
6.5
7
*
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
28.8
6.3
8
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
6.3
6
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
6.3
6
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.2
6.2
16
30
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.1
6.2
25
77
N02AA05
ATC
oxycodone; systemic
4.5
6.2
22
60
WZC30
NOMESCO Finland
Teaching
5.3
6.1
18
40
N30.0
ICD-10 Finland
Acute cystitis
5.0
6.1
19
45
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
149
668
4.03
26.30
8.4
3.1
—
—
—
0
0
79
268
3.84
20.17
6.7
2.9
0.8
0.8
mmol/l
2.16
72
241
148
764
3.28
19.01
6.0
3.6
—
—
—
0
0
42
92
5.28
18.77
3.8
1.5
9.7
6.0
ug/l
0.37
31
72
72
242
3.77
18.48
7.6
5.4
1.1
1.0
mmol/l
0.42
67
220
95
391
3.30
17.66
3.3
2.1
—
—
—
0
0
114
524
3.15
17.54
8.7
2.9
0.5
0.4
e6/l
0.12
98
393
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
31
65
5.30
14.44
3.4
2.5
0.4
0.3
u/ml
0.27
16
30
52
174
3.51
13.11
10.0
7.3
12.3
12.3
mmol/l
0.00
47
166
73
305
2.96
12.68
8.5
3.0
1.3
1.8
e6/l
0.34
52
177
55
200
3.24
12.10
6.2
3.9
5.9
5.8
kpa
0.27
55
191
55
200
3.24
12.10
6.2
3.9
1.4
1.9
mmol/l
0.47
48
160
138
830
2.47
11.19
11.3
5.4
1.2
1.2
mmol/l
0.06
127
713
42
137
3.48
10.93
2.2
1.8
0.2
0.2
g/l
0.55
34
116
131
776
2.44
10.90
9.0
3.5
32.1
35.0
g/l
5.97
122
713
146
912
2.44
10.73
15.4
5.4
4.9
4.5
e9/l
0.75
126
786
61
256
2.83
10.32
9.8
6.4
-0.9
1.5
mmol/l
5.18
50
197
71
328
2.62
9.93
8.3
2.7
2.5
1.0
e6/l
0.66
50
200
140
900
2.26
9.09
12.1
5.9
1.2
1.2
mmol/l
0.23
118
747
37
130
3.17
8.49
1.8
1.6
—
—
—
0
0
182
1336
2.32
8.15
13.2
5.0
92.1
76.9
u/l
1.27
174
1206
98
591
2.08
7.02
7.7
2.1
2.4
2.3
mmol/l
0.27
88
466
31
120
2.81
5.98
1.5
1.5
—
—
—
0
0
35
148
2.59
5.70
6.5
3.7
0.4
2.2
mmol/l
2.26
27
105
59
328
2.04
5.06
2.0
1.7
—
—
—
0
0
24
89
2.88
5.01
1.5
1.6
2.0
1.5
g/l
1.21
19
79
119
837
1.80
4.96
5.6
3.9
0.0
0.0
estimate
0.00
30
136
119
839
1.80
4.90
7.8
5.4
0.0
0.0
estimate
0.00
28
133
77
483
1.86
4.60
4.5
2.5
28.9
41.0
u/l
1.44
72
459
13
34
3.98
4.59
1.3
1.3
—
—
—
0
0
12
31
4.02
4.31
1.7
1.5
—
—
—
0
0
118
855
1.72
4.24
5.6
4.0
0.0
0.0
estimate
0.00
30
128
47
257
2.02
4.18
3.6
2.6
18.9
23.7
%
2.22
41
226
22
91
2.55
3.75
7.2
4.6
23.9
24.9
mmol/l
1.02
22
84
19
73
2.73
3.73
2.3
1.7
0.6
2.1
ug/l
1.07
14
61
33
167
2.12
3.59
4.2
3.2
4.8
4.5
kpa
0.31
33
157
18
70
2.69
3.46
2.7
4.0
—
—
—
0
0
41
229
1.94
3.42
1.9
1.8
—
—
—
0
0
9
18
5.14
3.40
2.1
2.4
—
—
—
0
0
41
230
1.94
3.38
1.9
1.8
—
—
—
0
0
76
518
1.67
3.27
2.6
2.1
3.2
2.9
mg/l
0.69
57
425
9
19
4.87
3.27
3.6
1.5
49.2
63.7
u/ml
—
9
19
58
371
1.73
3.14
6.0
2.1
2.5
2.4
mmol/l
2.59
50
304
5
5
10.16
2.99
1.2
1.6
—
—
—
0
0
5
5
10.16
2.99
1.2
1.6
—
—
—
0
0
13
50
2.69
2.57
1.3
1.3
—
—
—
0
0
13
50
2.69
2.57
1.3
1.3
—
—
—
0
0
5
7
7.26
2.56
1.4
1.0
3.5
6.0
nmol/l
—
5
7
8
21
3.90
2.48
1.4
1.2
—
—
—
0
0
5
8
6.35
2.38
1.2
1.1
—
—
—
0
0
14
59
2.45
2.33
1.4
1.3
—
—
—
0
0
195
1732
1.56
2.27
34.8
14.3
41.6
27.2
mg/l
6.40
182
1355
53
364
1.58
2.16
1.7
1.7
2.1
1.4
mg/l
0.77
48
280
6
15
4.07
2.05
4.0
1.1
—
—
—
0
0
63
461
1.49
1.92
6.1
4.2
0.0
0.0
estimate
0.00
19
132
22
123
1.86
1.87
1.8
1.6
—
—
—
0
0
5
12
4.23
1.83
1.2
1.2
—
—
—
0
0
6
18
3.39
1.75
1.5
1.3
—
—
—
0
0
89
707
1.40
1.74
3.7
2.7
247.7
151.0
ug/l
1.02
82
634
6
19
3.21
1.67
1.5
1.3
—
—
—
0
0
6
19
3.21
1.67
1.5
1.3
—
—
—
0
0
6
19
3.21
1.67
1.5
1.3
—
—
—
0
0
6
19
3.21
1.67
1.5
1.3
—
—
—
0
0
6
19
3.21
1.67
1.5
1.3
—
—
—
0
0
16
84
1.97
1.64
2.0
1.5
—
—
—
0
0
103
850
1.36
1.57
5.0
4.1
38.2
51.6
ng/l
0.88
91
651
0
44
0.00
1.53
0.0
1.7
—
4.6
—
0
30
64
492
1.40
1.49
4.0
2.6
405.0
9808.8
umol/l
2.73
53
415
103
856
1.34
1.48
2.3
2.1
91.6
92.5
pmol/l
0.07
74
446
25
158
1.65
1.44
1.8
1.7
64.9
66.6
g/l
0.68
20
137
9
40
2.30
1.41
2.0
1.3
—
—
—
0
0
25
160
1.62
1.38
7.6
5.8
23.6
24.3
mmol/l
0.47
25
154
14
76
1.89
1.32
2.1
1.4
—
—
—
0
0
28
190
1.53
1.23
6.4
3.2
—
—
—
0
0
153
1679
0.77
1.17
4.5
4.9
1.3
1.4
mmol/l
0.85
135
1499
148
1630
0.78
1.16
4.2
4.4
1.4
1.2
mmol/l
1.54
128
1445
79
652
1.31
1.15
6.7
4.2
—
—
—
0
0
54
424
1.35
1.10
6.0
3.9
75.4
429.4
ng/l
2.31
47
364
161
1750
0.78
1.10
5.0
5.6
2.4
2.5
mmol/l
0.81
142
1567
7
32
2.22
1.09
1.3
1.5
—
—
—
0
0
56
446
1.33
1.04
1.9
1.8
1074.6
1175.9
nmol/l
0.29
43
340
156
1696
0.79
1.02
4.5
5.0
4.3
4.3
mmol/l
0.20
137
1532
17
257
0.64
1.00
1.1
1.3
28.4
37.2
iu/ml
—
5
80
5
23
2.20
0.98
2.6
1.5
—
—
—
0
0
195
1832
1.29
0.90
15.8
9.1
23.8
25.0
u/l
0.54
186
1727
90
778
1.24
0.88
2.1
2.2
—
—
—
0
0
21
146
1.48
0.85
2.8
2.1
43.1
54.8
ml/min/173m2
0.90
11
53
6
31
1.96
0.85
3.0
1.4
—
—
—
0
0
6
31
1.96
0.85
3.0
1.5
—
—
—
0
0
174
1620
1.24
0.83
35.9
13.3
63.5
71.7
ml/min/173m2
4.54
155
1294
156
1677
0.82
0.81
7.7
7.0
42.7
41.5
mmol/mol
0.64
136
1520
197
1862
1.27
0.81
42.7
17.9
138.6
139.8
mmol/l
5.64
191
1791
197
1864
1.26
0.78
43.2
18.0
4.1
4.0
mmol/l
1.60
190
1795
159
1474
1.21
0.75
41.2
15.8
36.1
38.6
%
2.32
103
880
119
1074
1.21
0.75
4.9
4.2
5.2
2.2
ug/l
0.90
98
934
7
41
1.73
0.70
2.4
1.4
—
—
—
0
0
7
44
1.61
0.65
1.9
1.5
—
—
—
0
0
199
1898
1.23
0.65
50.1
21.0
123.1
135.7
g/l
17.74
194
1844
199
1898
1.23
0.65
49.7
20.8
4.2
4.5
e12/l
10.17
189
1810
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
37
442
0.81
0.54
1.8
1.7
1.3
1.3
mmol/l
0.10
30
350
58
511
1.18
0.46
1.7
1.6
19.4
20.8
nmol/l
0.28
50
425
130
1220
1.14
0.43
4.7
3.5
15.2
15.1
pmol/l
0.21
110
1064
22
270
0.80
0.42
17.1
7.5
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
513.1
—
0
12
0
18
0.00
0.40
0.0
1.0
—
36.0
—
0
12
63
569
1.14
0.37
2.7
2.8
1.1
0.8
ug/l
0.30
48
410
11
82
1.36
0.34
1.3
1.3
—
—
—
0
0
73
675
1.11
0.30
2.3
2.2
78.2
76.7
nmol/l
0.15
67
570
135
1301
1.08
0.22
4.7
4.2
20.3
13.0
mm/h
3.66
126
1163
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
840.6
—
0
10
26
292
0.88
0.21
1.3
1.2
1.1
1.5
u/ml
—
5
76
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
15
127
1.19
0.20
1.7
2.2
7.2
15.1
nmol/l
—
10
106
168
1716
0.94
0.16
5.3
5.1
6.3
6.2
mmol/l
0.38
145
1516
14
156
0.89
0.10
1.3
1.2
—
—
—
0
0
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
6
54
1.11
0.09
1.2
1.3
—
—
—
0
0
47
452
1.05
0.07
1.9
1.8
334210869.1
15922204.7
pmol/l
0.46
38
358
9
101
0.89
0.06
1.7
1.4
—
—
—
0
0
83
847
0.97
0.05
3.8
4.0
19.2
24.3
%
2.45
45
445
156
1575
0.97
0.04
5.7
4.3
2.0
2.0
mu/l
0.11
136
1372
101
1003
1.01
0.01
3.3
2.9
85.0
50.1
u/l
1.11
95
902
25
253
0.99
0.00
4.1
5.2
31.4
32.0
%
0.12
19
154
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
2480.6
—
0
7
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
57
0.87
0.00
1.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
63.2
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_URINARY_TRACT_NAS_EXALLC – Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).